Nurse Practitioner, Family · Las Cruces, NM
NPI
1356985428
Since 2019
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3865 E Lohman Ave Ste 4
Las Cruces, NM, 88011
Phone (575) 491-5085
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$4.6M
6,960 prescriptions
Company payments, 2025
$6,883
From 14 companies
Medicare prescription drug claims, 2024
In 2024, the drug Jamie R Lujan prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 997 prescriptions and refills. In total Jamie R Lujan wrote 6,960 Medicare prescriptions that cost $4.6M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-11-01.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 997 | 1,315 | 431 | $33K |
| Montelukast Sodium Generic | 688 | 1,685 | 260 | $8,470 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 631 | 900 | 143 | $565K |
| Symbicort Budesonide/Formoterol Fumarate | 339 | 598 | 114 | $131K |
| Spiriva Respimat Tiotropium Bromide | 333 | 607 | 104 | $311K |
| Azithromycin Generic | 321 | 549 | 161 | $4,106 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 301 | 533 | 86 | $249K |
| Fluticasone Propionate Generic | 271 | 607 | 133 | $6,673 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 228 | 359 | 66 | $222K |
| Prednisone Generic | 223 | 318 | 130 | $961 |
| Breo Ellipta Fluticasone/Vilanterol | 156 | 250 | 45 | $99K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 138 | 214 | 50 | $20K |
| Arnuity Ellipta Fluticasone Furoate | 135 | 209 | 44 | $45K |
| Azelastine Hcl Generic | 127 | 283 | 73 | $4,993 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 122 | 185 | 39 | $86K |
Brand drugs: 3,626 claims; generic drugs: 3,334 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jamie R Lujan $6,883 ($6,883 in general payments such as food, travel and fees) from 14 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $5,688.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 22 | $5,688 |
| GlaxoSmithKline, LLC. GSK | 15 | $253 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $178 |
| Viatris Specialty LLC | 7 | $149 |
| United Therapeutics Corporation UTHR | 3 | $120 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $99.5 |
| Verona Pharma, Inc. VRNA | 4 | $97.37 |
| Grifols USA, LLC | 4 | $74.13 |
| Abiomed JNJ | 1 | $62.06 |
| Baxter Healthcare BAX | 2 | $46.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.